Analysis of bone microstructure using second-generation high-resolution peripheral quantitative computed tomography (HR-pQCT) in patients with primary aldosteronism

Analysis of bone microstructure using second-generation high-resolution peripheral quantitative computed tomography (HR-pQCT) in patients with primary aldosteronism - Analysis of bone microstrucure using HR-pQCT in primary aldosteronism

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038531

Enrollment

100

Registered

2019-11-10

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with primary aldosteronism based on the criteria of Japan Endocrine socitety

Exclusion criteria

Exclusion criteria: 1. Patients treated at present or within 12 months with bisohosphonate, teriparatide, denosumab and romosozumab. 2. Patinets administered with steroids. 3. Patients compricated with malignancy. 4. Pregnant or brest feeding.

Design outcomes

Primary

Measure	Time frame
Bone microstructure compared to those of healthy control.	—

Secondary

Measure	Time frame
Changes in bone microstructure in patients with primary aldosteronism from baseline to 1 or 2 years after adrenalectomy.	—

Countries

Japan

Contacts

Public ContactHorie Ichiro

Nagasaki University Hospital Department of Endocrinology and Metabolism

horie@nagasaki-u.ac.jp0958197262

Outcome results